Osteoarthritis
-
Biologics
Lipogems® Receives IDE Approval From The U.S. FDA To Begin A Pivotal Clinical Study On The Safety And Effectiveness Of The Lipogems System For The Treatment of Knee Osteoarthritis
ATLANTA , June 10, 2022 /PRNewswire/ — Lipogems is pleased to announce the unconditional approval by the U.S. Food and Drug Administration (FDA) to…
Read More » -
Biologics
First Subjects Randomized and Dosed in the U.S. under Phase III Pivotal Trial for the Treatment of Pain Associated with Knee OA
Ongoing trial to assess the potential of Zilosul™ to address unmet medical need in OA which affects more than 72 million…
Read More » -
Recon
New Invention Stops or Delays the Progression of Osteoarthritis of the Knee
NEW YORK, April 1, 2021 /PRNewswire/ — New York Bone & Joint Specialists is at the forefront of orthopedic technology, with an exciting…
Read More » -
Extremities
Ensemble Orthopedics Announces Successful First Implantation Of Its Pyrocarbon Interpositional CMC
AUSTIN, Texas, March 25, 2021 /PRNewswire/ — Ensemble Orthopedics, Inc. announced today the first implantation of the FDA-cleared Ensemble CMC™, the first implant…
Read More » -
Biologics
Organogenesis ReNu® Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation For Osteoarthritis of the Knee
FDA Determines ReNu Preliminary Clinical Evidence Indicates Potential to Address Unmet Medical Needs for the Management of Symptoms Associated with…
Read More » -
Biologics
Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA
November 18, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…
Read More » -
Recon
Total Joint Replacement and the Impact on Future Falls in Osteoarthritis Patients
ROSEMONT, Ill., Oct. 16, 2020 /PRNewswire/ — Patients who have had a total joint arthroplasty (TJA) demonstrate excellent long-term outcomes with increased…
Read More » -
Biologics
Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide
September 22, 2020 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing…
Read More » -
Biologics
New Approach to Treating Osteoarthritis Advances
NEW YORK, Aug. 10, 2020 /PRNewswire/ — Injections of a natural “energy” molecule prompted regrowth of almost half of the cartilage lost…
Read More » -
Extremities
CyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis Pain
SCOTTSDALE, Ariz., June 16, 2020 CyMedica Orthopedics®, the leading combined muscle strengthening therapy and digital health innovator, announced today that…
Read More » -
Biologics
Bioventus Selects Bazis NN as Distributor of DUROLANE® in Russia
June 15, 2020 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, has selected Bazis NN as its authorized distributor for DUROLANE,…
Read More »